Indeed, certain cancer cells upregulate the gene expression of the glucose transporters GLUT1 (SLC2A1) and GLUT3 (SLC2A3) to increase glucose uptake, which correlates with poor prognosis. This evidence concerns the gene SLC2A3 and cancer.